Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-28 15:17 | Swedish | 14.3 KB | |||
| 2025-05-28 15:11 | Swedish | 10.6 KB | |||
| 2025-05-28 14:27 | Swedish | 11.0 KB | |||
| 2025-05-26 18:00 |
Alligator Bioscience AB genomför riktade nyemissioner till garanter i samband m…
|
Swedish | 88.1 KB | ||
| 2025-05-26 18:00 |
Alligator Bioscience AB carries out directed issues to guarantors in connection…
|
English | 89.7 KB | ||
| 2025-05-26 12:36 | Swedish | 11.0 KB | |||
| 2025-05-23 10:26 | Swedish | 10.5 KB | |||
| 2025-05-21 14:45 |
Alligator Bioscience AB announces final outcome of exercise of warrants series …
|
English | 72.5 KB | ||
| 2025-05-21 14:45 |
Alligator Bioscience AB meddelar slutligt utfall för nyttjandet av teckningsopt…
|
Swedish | 71.8 KB | ||
| 2025-05-20 12:30 |
Alligator Bioscience AB meddelar preliminärt utfall för nyttjandet av tecknings…
|
Swedish | 64.9 KB | ||
| 2025-05-20 12:30 |
Alligator Bioscience AB announces preliminary outcome of exercise of warrants s…
|
English | 64.7 KB | ||
| 2025-05-15 08:30 |
Sista dag för handel med teckningsoptioner serie TO 12 i Alligator Bioscience ä…
|
Swedish | 68.5 KB | ||
| 2025-05-15 08:30 |
Last day of trading in warrants series TO 12 in Alligator Bioscience is 15 May …
|
English | 69.1 KB | ||
| 2025-05-14 10:13 | Swedish | 10.6 KB | |||
| 2025-05-12 10:12 | Swedish | 10.6 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
